{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:24:23Z","timestamp":1761171863021,"version":"build-2065373602"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Leiomyosarcomas are uncommon mesenchymal neoplasms. Primary mediastinal leiomyosarcomas are even rarer with only a limited number of cases reported. Given the high potential for recurrence and metastasis, accurate and timely diagnosis become extremely crucial for treatment. Herein, we present a unique case of a 70-year-old asymptomatic male patient with a primary leiomyosarcoma originating from the azygos vein, which was misdiagnosed as a tracheal tumor preoperatively. This report highlights the critical importance of including leiomyosarcoma in the differential diagnosis of mediastinal masses, especially when preoperative pathological findings indicate a spindle cell neoplasm of smooth muscle origin. Early recognition can more effectively assess intraoperative risks, optimize the surgical plan, and are essential to prevent locally invasive growth and potential metastasis. By analyzing the specific case and reviewing relevant literature, this study seeks to enhance our understanding of the diagnosis and treatment of primary mediastinal leiomyosarcoma, derive insights from our clinical experience, and emphasize the importance of maintaining suspicion and prudence among healthcare professionals.<\/jats:p>","DOI":"10.3389\/fonc.2025.1639131","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:17:33Z","timestamp":1761106653000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary leiomyosarcoma originating from the azygos vein misdiagnosed as tracheal tumor: a case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Long-fei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-jian","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-lin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.3390\/diagnostics12112581","article-title":"Primary leiomyosarcoma of the mediastinum: A rare and challenging diagnosis","volume":"12","author":"Mancini","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2018.03.068","article-title":"Treatment approaches and outcomes for primary mediastinal sarcoma: analysis of 976 patients","volume":"106","author":"Engelhardt","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0003-4975(98)00718-8","article-title":"Resection of a leiomyosarcoma of the azygos vein","volume":"66","author":"Dasika","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cireng.2022.06.008","article-title":"Leiomyosarcoma of the azygos vein. An unusual case","volume":"101","author":"D\u00edaz-Garc\u00eda","year":"2023","journal-title":"Cir Esp (Engl Ed)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.15467","article-title":"A case of leiomyosarcoma originating from the azygos vein","volume":"15","author":"Shimura","year":"2024","journal-title":"Thorac Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1148\/radiographics.22.3.g02ma17621","article-title":"Primary thoracic sarcomas","volume":"22","author":"Gladish","year":"2002","journal-title":"Radiographics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002436","article-title":"A case of mediastinal leiomyosarcoma demonstrated on FDG PET\/CT imaging","volume":"44","author":"Wu","year":"2019","journal-title":"Clin Nucl Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23592","article-title":"A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma","volume":"113","author":"Pervaiz","year":"2008","journal-title":"Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/cancers16050938","article-title":"The future of targeted therapy for leiomyosarcoma","volume":"16","author":"Denu","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4070","article-title":"FDA approval summary: pembrolizumab for the treatment of microsatellite instability-high solid tumors","volume":"25","author":"Marcus","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0327","article-title":"FDA approval summary: pembrolizumab for the treatment of tumor mutational burden-high solid tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/cells13131106","article-title":"Comprehensive review of uterine leiomyosarcoma: pathogenesis, diagnosis, prognosis, and targeted therapy","volume":"13","author":"Yang","year":"2024","journal-title":"Cells"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1639131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:17:35Z","timestamp":1761106655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1639131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":14,"alternative-id":["10.3389\/fonc.2025.1639131"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1639131","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"article-number":"1639131"}}